ACAAI Asthma Committee Chair Dr Jon Romeo predicts novel monoclonal antibodies and an emphasis on precision medicine could transform asthma care in 2022.
Does a patient’s sex or asthma status affect the level of respiratory symptoms they will experience from occupational environmental exposures or increasing BMI?